Small Cap Feast

Small Cap Feast – 4th October 2016

Dish of the Day:

No AIM Primary Today

Off the Menu:

Avanti Capital (AVA.L) delisting after the sale of core investments

What’s Cooking in the IPO Kitchen?

Premier Asset Management— the retail asset management group has raised £63.7m at  132p and is due to join AIM on 7 October.

ConvaTec — The medical products manufacturer is expected to announce a planned London IPO according to City A.M. Other reports suggest a valuation of circa £5 billion.

O2—Press reports that Telefonica will bring O2 to the LSE this year with a large retail offer. This has not yet been confirmed

Biffa— Intention to float announcement states that up to £270m  is to be raised to pay down debt and historic landfill tax liability.


Breakfast Buffet

TMT Investments* (TMT.L) $2.13 $58.96

Following five years of active investing activity since  admission AIM in December 2010 and the successful partial cash exit from Depositphotos in March 2016, the Company’s Board  has resolved to declare a one-off dividend  for a total amount of US$2,774,496, or US$0.10 per ordinary share.  The dividend payment will be made on 18 November 2016.  The record date for the payment of the dividend for all ordinary shares is 4 November 2016, with an ex-dividend date of 3 November 2016.


Milestone Group* (MSG.L) 1p £7.84m

The provider of digital media and technology solutions and the Social Stock Exchange  has announced the signing of a cooperation agreement with the Social Stock Exchange specifically aimed at generating revenues, building membership and raising the profile of both organisations. The  agreement will involve, introducing new members to each organisation, joint promotion, developing strategic partnerships and establishing an investment fund.


Venn Life Sciences* (VENN.L) 22.13p £13.3m

The growing Contract Research Organisation has announced an agreement to sell its Innovation Division Innovenn for up to £4.74m largely in shares in Integumen. A book gain of circa £959k. Integumen plans to seek admission to AIM in due course and plans to raise capital to fund the future development and commercialisation of the technology portfolio. In addition to the acquisition of Innovenn, Integumen is in the process of acquiring three complementary businesses  in the areas of Skin Science, Oral-health and Woundcare.


AB Dynamics (ABDP.L) 477.5p £84.83m

FYAUG16 trading update from the designer, manufacturer and supplier of advanced testing systems and measurement products to the global automotive industry. The Group has performed well in 2016 and the Board expects to report revenues and profit before tax (excluding share option charge) in line with market forecasts. Construction of the new facility is in full progress with completion expected by the Q3 2017. FY16E revenues of £20.4m and EPS of 22.5p rising to28p for FY17E. 2016E PE of 21.2x and 0.6% yield.


Vela Technologies (VELA.L)0.15p £1.05m

The investing company focused on early stage and pre-IPO disruptive technology investments  is investing £200k in THEVIBE Ltd, a Lancashire-based disruptive ticketing platform. Vibe Tickets is currently undertaking a c.£600,000 equity fundraising through Crowdcube, the crowdfunding platform. Vibe Tickets is an open fan-to-fan ethical ticketing platform that allows fans to exchange tickets for face value or less with other trusted members of the Vibe community. Vibe is currently pre-revenue.


Digital Globe Services (DGS.L) 46.62p £13.88m

FYJun16 finals from the provider of digital marketing solutions for large, consumer-facing organisations. Record revenues. Revenue increased 19% to $47.8M. Gross margin compression in H2 due primarily to increased marketing investment in core business and new verticals. Gross margin for the year of 27.6% (32.7%). GP flat at $13.2m. Adjusted EBITDA of $2.5M ( $3.0M). Outlook: 2016 Investments will drive margin expansion and profitable growth for the year ahead. FY17 trading expected to show continued revenue growth and a significant increase in profitability.


Watkin Jones (WJG.L) 124.75p £318.45m

The UK developer and constructor of multi occupancy property assets, with a focus on the student accommodation sector, announced today that it has forward sold its development in St. Mungo Avenue, Glasgow to a new institutional investor for an undisclosed fee. The seven storey 349 bed scheme (176 cluster bedrooms and 173 studios) is due for delivery in August 2018, ahead of the 2018-19 academic year.


easyHotel (EZH.L) 101.5p £58.44m

The owner, developer, operator and franchisor of “super budget” branded hotels, confirms it has been granted planning permission for a 204-room easyHotel located on Gran Via, the main avenue of L’Hospitalet de Llobregat to the southwest of Barcelona. easyHotel’s acquisition of the land for the new build easyHotel is expected to complete in the coming weeks and the hotel is expected to open in early 2018.


FinnAust Mining (FAM.L) 7p £34.61m

The company with projects in Greenland & Finland, has announced significant advances in optimising the metallurgical processes required to produce an ilmenite concentrate from the Pituffik Titanium Project in Greenland. Successful test work demonstrates ability to produce a gravity-separated concentrate that compares favourably against existing ‘hard rock’ sources of ilmenite. Maiden JORC resource expected later this year ahead of a 2017 bulk sampling programme.


Volga Gas (VGAS.L) 48p £38.82m

The oil and gas exploration and production group operating in the Volga Region of Russia, has announced its average production volumes for August 2016 and for the year to date. Average Group production for the September 2016 was 7,927 barrels of oil equivalent per day (11.9% higher than August 2016).  This was the highest monthly production rate achieved in 2016


Head Chef:

Emily Liu, CFA, CAIA
0203 764 2344

Sous Chef:

Sacha Morris
0203 764 2345

*A corporate client of Hybridan LLP


This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.

The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).

Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.

Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.

Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.

MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.

If you would like to unsubscribe, please email with “unsubscribe me”.